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The treatment of hyperthyroidism with antithyroid
drugs can cause a significant side effect in 0.2 to 0.3% of
the cases: agranulocytosis. Infectious complications caused
by this condition affect mainly the throat, and tonsillitis is
one of its manifestations. The present study reported the
case of a female patient, 33 years old, manifesting
odynophagia and fever resistant to many antibiotics. The
patient showed hyperthyroidism and had been using
methimazole for two months. With the diagnoses of
agranulocytic angina, the drug was withdrawn and
treatment with ciprofloxacin, symptomatic drugs and
granulocytic-colony stimulator, besides fluconazol was
started. The patient developed satisfactorily, being
discharged ten days after the beginning of the treatment.
Fifteen days later, total thyroidectomy was carried out.
The purpose of this report was to point out the importance
of knowing the side effects of drugs to advise the patients
about them and to warn physicians about the need for
evaluating the patient as a whole, searching for other
current diseases and drugs in use.
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INTRODUCTION
Hyperthyroidism consists of an increase in synthesis
and release of thyroid hormones and thyrotoxicosis is the
resulting clinical syndrome 1. It is a common disease, with
predominance of 0.2 to 0.5% in the population 2. The most
frequent cause of thyrotoxicosis is Basedow-Graves disease
or toxic diffuse goiter, responsible for 60 to 90% of the cases,
and observed in women at a frequency of 1.9%, with a peak
between the ages of 20 and 40 anos1. It is an autoimmune
disease with family tendency and association with other
endocrine autoimmune diseases (IDDM and Adisson) and
non-endocrine diseases (pernicious anemia, myasthenia,
rheumatoid arthritis, Sjögren disease, vitiligo and chronic
active hepatitis)3.
Regardless of the cause factor, signs and symptoms
resulting from thyrotoxicosis are: nervousness, emotional
instability, fatigue, excessive sudoresis, weight loss, tremors,
tachycardia, ocular complaints (GRAVES disease) and goiter.
Some environmental factors trigger an immune response in
Graves such as: pregnancy, iodine excess, lithium therapy,
renal infections (since they induce expression of DR4 in
follicular cells) or bacterial infections (Yersinia enterocolitica
has cross reaction with thyroid antigens) and use of
corticosteroids 5.
The increase in thyroid size, infiltration,
ophthalmopathy and dermopathy are mediated by
autoimmune processes, differentiating Graves disease from
other causes of thyrotoxicosis 1.
There are three main treatment approaches: anti-
thyroid drugs, surgery and radioiodine, but initial therapy
normally prefers pharmacological treatment, frequently
methimazole 4,6. It is a drug derived from thyourea or
thyonamide that inhibits oxidation of iodine captured by
the thyroid and as a consequence, it prevents synthesis of
thyroid hormones 7.
The less uncommon side effect of the use of thyourea,
even though very important, is agranulocytosis 1. It may be
present regardless of age, dose and treatment duration 8,
even though Meyer-Gebner et al. have reported higher
incidence with higher doses 6. It has sudden onset and affects
0.2 to 0.3% of the patients 8,9. Tamai et al., after a review of
7,000 patients with diagnosis of Basedow-Graves, found
agranulocytosis in only 12 patients with incidence of 0.17%8.
To Meyer-Gebner et al. The incidence found in 1,256 studied
patients was of 0.18%6.
Based on this side effect, patients need to be instructed
to stop medication and get in contact with their physician in
case of fever or infection, especially of the oropharynx,
considering that the clinical evidence of infections associated
with the use of anti-thyroid drugs is usually symptomatic in
this region 1,8,9. Periodontal, periapical and oral mucosa
infections tend to aggravate quite quickly and they are the
main foci of infection, and gram negative are the most
common agents 10. Monitoring of patients by routine counting
of leukocytes has been proposed by same authors as
effective in the prevention of agranulocytosis 11. However,
there is no literature consensus and according to Meyer-
Gebner et al. it would be important to have appropriate
patient guidance for them to identify the symptoms of the
disease 6.
Agranulocytic angina ranges from simple erythema
to ulceration and necrosis of buccopharyngeal mucosa 12.
There is no tendency to hemorrhage, nor generalized
lymphadenopathy and splenomegalia, such as in acute
leukemia 12. Complete blood count shows marked
leukocytopenia: 2,000, 1,000, 500 leukocytes /mm3, together
with neutropenia, which may be of 0% 12. There are no
abnormal or immature leukocytes. Red blood cells and
platelets are not affected 12. The identification of
agranulocytosis using complete blood count requires
management of wide-spectrum antibiotics, especially against
Pseudomonas aeruginosa, as well as support therapy.
Currently, agranulocytosis induced by methimazole is a
reversible process 9,10.
The purpose of the present study was to
present an uncommon case of agranulocytic angina caused
by use of methimazole and to warn physicians about the
need to consider this diagnosis in patients that have taken
this medication. It is especially recommended that these
patients be informed about the possible drug side effects, a
practice that may prevent suffering and unnecessary costs.
CASE REPORT
Female patient aged 33 years, came to the outpatient
unit of Otorhinolaryngology, University Hospital, Medical
School, Itajubá (MG), with complaint of odynophagia and
fever for one month. In the anamnesis, she showed to be
taken aback and anxious with the persistence of her
complaints, even after the use of different drugs, as confirmed
by a number of prescriptions she had: penicillin benzatin,
sulfamethoxazole + trimetoprim, amoxicillin, lincomycin and
ceftriaxone.
During patient’s examination, we detected marked
exophthalmia associated with the presence of goiter. When
asked about it, she informed that for 2 months she had started
clinical treatment fort hyperthyroidism with methimazole
80mg/day. She informed that the physician had not instructed
her to interrupt treatment in case of fever or sore throat.
ENT physical examination showed positive data for
the presence of erythematous tonsillitis and cervical
lymphadenomegalia (Figures 1 and 2). The general
examination showed tachycardia and tachypnea. She was
febrile and hypotense. Based on the diagnostic hypothesis
of agranulocytic angina secondary to methimazole, we
requested a complete blood count that showed significant
leukopenia: 1,300/mm3. For the differential diagnosis, we
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also requested serology for infectious mononucleosis and
AIDS, which were negative.
We decided to hospitalize the patient and to jointly
follow her up with the clinical practice medicine in the
hospital. We ordered a myelogram to exclude the presence
of some possible myeloproliferative diseases, excluded after
the result. The treatment was performed by suspending
methimazole, administering symptomatic and vasopressure
drugs, intravenous antibiotic therapy with ciprofloxacin and
granulocytic colony stimulating agent.
During hospitalization, she presented affection of the
oropharynx with diffuse apthae and monolyasis (Figure 3),
when we started treatment with fluconazole 300 mg/day.
She presented satisfactory evolution, with progressive
increase of leukocyte count and remission of oral lesions,
being discharged with good general status after 10 days of
hospital stay. Fifteen days after the discharge, she was
submitted to total thyroidectomy for definitive cure of
thyrotoxicosis and currently she is followed up as an
outpatient by endocrinology.
DISCUSSION
The case reported here is of a patient who came to
the Service of Otorhinolaryngology and whose main
complaint was odynophagia and fever; she had been
submitted to different antimicrobial treatment regimens, with
different spectrum coverage, all of them without any efficacy.
At that time, it was essential to collect a detailed history,
especially concerning other systemic diseases that could
interfere with the immune system of the patient and recent
treatment of other pathologies. In view of the fact that she
had been using methimazole for the treatment of
hyperthyroidism, associated with exophthalmia and goiter,
we suspected of a case of tonsillitis with modification of
leukocyte count, a suspicion confirmed by the leukocyte
count test.
According to the studied literature, agranulocytosis is
a very infrequent side effect in patients treated with
methimazole 1,6,8,9. On average, the onset of this complication
is present in the first weeks of treatment with the referred
drug 6. In the present study, the patient had been taking the
drug for 2 months.
According to the literature, antibiotics, corticoids and
granulocytic colony stimulators are the most frequently used
drugs to treat agranulocytosis 2,6,9. In the reported case, the
patient improved her manifestations by symptomatic
medication, fluconazole, ciprofloxacin and granulocytic
colony stimulator. Moreover, the patient was followed up
also by the general clinical care of the institution.
This report shows the importance of considering the
patient as a whole, trying to associate signs and symptoms
to a possible systemic impairment caused by other diseases
or as a side effect of some drug in use. It is important to
Figure 1. Oropharyngoscopy showing erythematous aspect of
palatine tonsils, uvula edema and tongue monolyasis.
Figure 3. Aphthous lesions affecting the hard palate and jugal
mucosa.
Figure 2.  Neck inspection: note the goiter and lateral chain
lymphoadenomegaly.
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make physicians aware of the need to get to know the
most severe side effects and to inform patients about the
situations that may take place during treatment and that can
pose a risk to their lives.
REFERENCES
1. Maciel RMB. In: Cintra do Prado F, Ramos J, Ribeiro do Valle J.
Atualização Terapêutica. 18ª ed. São Paulo: ed. Artes Médicas;
1997. p. 478-9.
2. Mackenzie J, Maxwell, Zakarija M. Hyperthyroidism. 1998; 1:
926-67.
3. Ingbar SH. In: Wilson JDF, Daniel W, Williams. Tratado de
endocrinologia. 7ª ed. Philadelphia: W.B. Saunders Company; 1988.
Vol. 1; p. 926-67.
4. Andreoli TE, Carpenter CCJ, Benett JC, Plum F. Cecil Medicina
Interna Básica. 4ª ed. Rio de Janeiro: Guanabara Koogan; 1997.
p. 471-2.
5. Greenspan FS. In: Greenspan FS, Baxter JD. Basic and Clinical
Endocrinology. 3ª ed. Connecticut: Prentice-Hall International Inc;
1994. p.200-10.
6. Meyer-Gebner, M.Benker G, Lederbogen S, Olbricht T, Reinwein
D. Antithyroid drug-induced agranulocytosis: Clinical experience
with ten patients treated at one institution and review of the
literature. J Endocrinol. Invest. 1994; 17: 29-36.
7. Greenspan FS, Dong BJ. In: Katzung BG. Farmacologia Básica e
Clínica. 6ª ed. Rio de Janeiro: Guanabara Koogan; 1996. p. 447.
8. Tamai H, Takaichi Y, Morita T, Komaki G, Matsubayashi S, Kuma
K, Walter RM, Kumagay LF, Nagataki S. Methimazole-induced
agranulocytosis in japanese patients with Graves’ disease. Clinical
Endocrinology. 1989; 30: 525-30.
9. Sheng WH, Jung CC, Chen YC, Fang CT, Hsieh SM, Chang SC,
Hsieh WC. Antithyroid-drug-induced agranulocytosis complicated
by life-threatening infections. QJ Med. 1999; 92: 455-61.
10. Hou GL, Tsai CC. Oral manifestations of agranulocytosis associated
with Methimazole therapy. J. Periodontol. 1988; 59: 244-8.
11. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-
induced agranulocitosis. Arch Intern Med. 1990; 150: 621-4.
12. Hungria H. Otorrinolaringologia. 8ª ed. Rio de Janeiro: Guanabara
Koogan; 2000. p.154.
